Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

NCT01388166

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 58 Baja, Hungary
  • Boehringer Ingelheim Investigational Site 85 Békéscsaba, Hungary
  • Boehringer Ingelheim Investigational Site 61 Budapest, Hungary
  • Boehringer Ingelheim Investigational Site 62 Budapest, Hungary
View all 90 locations
View Trial Details
Completed

Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.

NCT01684384

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Antwerp University Hospital Edegem, Antwerp, Belgium
  • University of Florence Florence, Italy
  • University Medical Center Groningen Groningen, Netherlands
  • Maastricht University Medical Center Maastricht, Netherlands
View Trial Details
Completed

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01696058

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1222.52.02090 Boehringer Ingelheim Investigational Site Anniston, Alabama, United States
  • 1222.52.02046 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1222.52.02014 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1222.52.02017 Boehringer Ingelheim Investigational Site Montgomery, Alabama, United States
View all 94 locations
View Trial Details
Completed

A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

NCT02172560

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 61501 Garran, Australian Capital Territory, Australia
  • Boehringer Ingelheim Investigational Site 61403 Clayton, New South Wales, Australia
  • Boehringer Ingelheim Investigational Site 61502 Adelaide, South Australia, Australia
  • Boehringer Ingelheim Investigational Site 61401 Woodsville South, South Australia, Australia
View all 19 locations
View Trial Details
Completed

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

NCT01543919

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Jasper, Alabama, United States
View all 132 locations
View Trial Details
Completed

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

NCT01019694

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1012.62.153 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 1012.62.145 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1012.62.156 Boehringer Ingelheim Investigational Site Mesa, Arizona, United States
  • 1012.62.135 Boehringer Ingelheim Investigational Site Berkeley, California, United States
View all 55 locations
View Trial Details

Related conditions